Company: GURE
Filing Date: 2025-12-15
Form Type: 8-K
Source: 0001193805-25-001737
Chunk: 0

Company: GULF RESOURCES, INC.
Filing Date: 2025-12-15
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

On December 10, 2025, Shouguang City
Haoyuan Chemical Company Limited (the “ Seller”), a company incorporated in the PRC and an indirect wholly owned subsidiary
of Gulf Resources, Inc. (the “ Company”), entered into an equity transfer agreement (the “ SPA”) with Shandong Rongyuan
Pharmaceutical Co., Ltd. (the “ Purchaser”) and Shouguang Yuxin Chemical Industry Co., Limited (the “ Target Company”).

Pursuant to the SPA, the Seller agreed
to sell, and the Purchaser agreed to purchase, 100% of the equity interests in the Target Company for an aggregate consideration of RMB
21.2 million (payable in instalments through 2028), subject to the terms and conditions set forth in the SPA (“ Sale”). The
Company’s board of directors (“ Board”) reviewed the terms of the SPA, including the consideration, conditions and payment
arrangements. The Board affirmed the Seller’s entry into the SPA and affirmed that the SPA and the transaction thereunder are fair
to, and in the best interests of, the Company and its shareholders as a whole.

Due to the prolonged suspension of operations at the Yuxin Chemical
facility, which has adversely affected the Company’s performance, the Board believes that, following the Sale, it will no longer
retain any burdens associated with such facility and will be able to focus resources on its other more profitable business segments.

The foregoing description of the
SPA does not purport to be complete and is qualified in its entirety by reference to the full text of the SPA, a form of which is filed
herein as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

Statements contained herein relating
to the Company or its management’s intentions, hopes, beliefs, expectations or predictions of the future, constitute forward looking
statements. Such forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks contained
in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on April 11, 2025, the Company’s
Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the SEC on November 19, 2025, and in the Company’s
other filings and submissions with